4D Molecular Therapeutics, Inc. (FDMT) SEC filings
FDMT SEC filings moved a median of -0.59% by the close. FDMT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the FDMT overview →
69 measured FDMT SEC filing events.
Where these FDMT SEC filings landedvs 69 measured FDMT SEC filing reactions
| Middle 50% of FDMT SEC filing reactions | -5.47% to +2.09% |
|---|---|
| Median reaction (to close) | -0.59% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 FDMT SEC filing events with a measured close landed between -5.47% and +2.09%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K 4D Molecular Therapeutic For: Sep 28 | SEC filing · Form 8-K | -0.80% | +0.62% | |
| Form 10-Q 4D Molecular Therapeutic For: Jun 30 | SEC filing · Form 10-Q | -1.80% | +4.82% | |
| Form 8-K 4D Molecular Therapeutic For: Aug 13 | SEC filing · Form 8-K | -1.80% | +4.82% | |
| Form 8-K 4D Molecular Therapeutic For: Jul 18 | SEC filing · Form 8-K | +0.55% | +1.93% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 24 | SEC filing · Form 8-K | +1.03% | +10.27% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form 8-K | +2.64% | +13.50% | |
| Form EFFECT 4D Molecular Therapeutic | SEC filing · Form EFFECT | -1.76% | -6.48% | |
| Form 10-Q 4D Molecular Therapeutic For: Mar 31 | SEC filing · Form 10-Q | +5.12% | +11.67% | |
| Form 8-K 4D Molecular Therapeutic For: May 07 | SEC filing · Form 8-K | +5.12% | +11.67% | |
| Form S-3 4D Molecular Therapeutic | SEC filing · Form S-3 | +5.12% | +11.67% | |
| Form ARS 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form ARS | +0.86% | -5.47% | |
| Form DEF 14A 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form DEF | +0.86% | -5.47% | |
| Form DEFA14A 4D Molecular Therapeutic | SEC filing · Form DEFA14A | +0.86% | -5.47% | |
| Form 8-K 4D Molecular Therapeutic For: Mar 25 | SEC filing · Form 8-K | +4.10% | +5.92% | |
| Form 10-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 10-K | -10.56% | -9.66% | |
| Form 8-K 4D Molecular Therapeutic For: Mar 18 | SEC filing · Form 8-K | -10.56% | -9.66% | |
| Form S-8 4D Molecular Therapeutic | SEC filing · Form S-8 | -10.56% | -9.66% | |
| Form 8-K 4D Molecular Therapeutic For: Jan 22 | SEC filing · Form 8-K | +1.26% | +6.79% | |
| Form 8-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 8-K | +1.10% | +6.58% | |
| Form 8-K 4D Molecular Therapeutic For: Dec 10 | SEC filing · Form 8-K | +1.01% | +0.00% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 17 | SEC filing · Form 8-K | +1.89% | +3.40% | |
| Form 10-Q 4D Molecular Therapeutic For: Sep 30 | SEC filing · Form 10-Q | -0.14% | -1.64% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 10 | SEC filing · Form 8-K | -0.14% | -1.64% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 06 | SEC filing · Form 8-K | -0.14% | -1.64% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 06 | SEC filing · Form 8-K | -0.04% | -3.79% | |
| Form 8-K 4D Molecular Therapeutic For: Oct 31 | SEC filing · Form 8-K | -1.72% | -3.77% | |
| Form 8-K 4D Molecular Therapeutic For: Sep 30 | SEC filing · Form 8-K | +0.69% | -2.06% | |
| Form 10-Q 4D Molecular Therapeutic For: Jun 30 | SEC filing · Form 10-Q | -0.89% | -1.60% | |
| Form 8-K 4D Molecular Therapeutic For: Aug 11 | SEC filing · Form 8-K | -0.89% | -1.60% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 27 | SEC filing · Form 8-K | -0.23% | -1.62% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form 8-K | -1.16% | -8.94% | |
| Form 10-Q 4D Molecular Therapeutic For: Mar 31 | SEC filing · Form 10-Q | +0.46% | -5.23% | |
| Form 8-K 4D Molecular Therapeutic For: May 08 | SEC filing · Form 8-K | +0.46% | -5.23% | |
| Form S-8 4D Molecular Therapeutic | SEC filing · Form S-8 | +0.46% | -5.23% | |
| Form ARS 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form ARS | +1.72% | +5.64% | |
| Form DEF 14A 4D Molecular Therapeutic For: Jun 17 | SEC filing · Form DEF | +1.72% | +5.64% | |
| Form DEFA14A 4D Molecular Therapeutic | SEC filing · Form DEFA14A | +1.72% | +5.64% | |
| Form EFFECT 4D Molecular Therapeutic | SEC filing · Form EFFECT | +0.76% | -6.22% | |
| Form 10-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 10-K | +3.50% | -9.41% | |
| Form 8-K 4D Molecular Therapeutic For: Feb 28 | SEC filing · Form 8-K | +3.50% | -9.41% | |
| Form POS AM 4D Molecular Therapeutic | SEC filing · Form POS | +3.50% | -9.41% | |
| Form POSASR 4D Molecular Therapeutic | SEC filing · Form POSASR | +3.50% | -9.41% | |
| Form S-8 4D Molecular Therapeutic | SEC filing · Form S-8 | +3.50% | -9.41% | |
| Form 8-K 4D Molecular Therapeutic For: Feb 08 | SEC filing · Form 8-K | -8.38% | -12.73% | |
| Form 8-K 4D Molecular Therapeutic For: Jan 10 | SEC filing · Form 8-K | -3.38% | -6.76% | |
| Form 8-K 4D Molecular Therapeutic For: Dec 06 | SEC filing · Form 8-K | -0.88% | +0.44% | |
| Form 10-Q 4D Molecular Therapeutic For: Sep 30 | SEC filing · Form 10-Q | -3.18% | +1.91% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 13 | SEC filing · Form 8-K | -3.18% | +1.91% | |
| Form 8-K 4D Molecular Therapeutic For: Sep 18 | SEC filing · Form 8-K | -9.43% | -22.37% | |
| Form 10-Q 4D Molecular Therapeutic For: Jun 30 | SEC filing · Form 10-Q | -0.54% | -5.61% | |
| Form 8-K 4D Molecular Therapeutic For: Aug 08 | SEC filing · Form 8-K | -0.54% | -5.61% | |
| Form 8-K 4D Molecular Therapeutic For: Jul 23 | SEC filing · Form 8-K | -0.54% | +6.59% | |
| Form 8-K 4D Molecular Therapeutic For: Jul 17 | SEC filing · Form 8-K | -14.49% | -37.00% | |
| Form 8-K 4D Molecular Therapeutic For: Jun 07 | SEC filing · Form 8-K | +0.67% | +0.67% | |
| Form 8-K 4D Molecular Therapeutic For: May 21 | SEC filing · Form 8-K | -1.21% | -2.51% | |
| Form 10-Q 4D Molecular Therapeutic For: Mar 31 | SEC filing · Form 10-Q | +0.69% | +2.02% | |
| Form 8-K 4D Molecular Therapeutic For: May 09 | SEC filing · Form 8-K | +0.69% | +2.02% | |
| Form ARS 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form ARS | -0.42% | +1.88% | |
| Form DEF 14A 4D Molecular Therapeutic For: May 21 | SEC filing · Form DEF | -0.42% | +1.88% | |
| Form DEFA14A 4D Molecular Therapeutic | SEC filing · Form DEFA14A | -0.42% | +1.88% | |
| Form 10-K 4D Molecular Therapeutic For: Dec 31 | SEC filing · Form 10-K | -1.58% | +2.09% | |
| Form 8-K 4D Molecular Therapeutic For: Feb 29 | SEC filing · Form 8-K | -1.58% | +2.09% | |
| Form S-8 4D Molecular Therapeutic | SEC filing · Form S-8 | -1.58% | +2.09% | |
| Form 8-K 4D Molecular Therapeutic For: Feb 06 | SEC filing · Form 8-K | +1.50% | -2.96% | |
| Form S-3ASR 4D Molecular Therapeutic | SEC filing · Form S-3ASR | -3.32% | +0.73% | |
| Form 8-K 4D Molecular Therapeutic For: Jan 01 | SEC filing · Form 8-K | +5.21% | -0.59% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 16 | SEC filing · Form 8-K | +1.90% | +1.57% | |
| Form 10-Q 4D Molecular Therapeutic For: Sep 30 | SEC filing · Form 10-Q | +0.49% | -0.45% | |
| Form 8-K 4D Molecular Therapeutic For: Nov 09 | SEC filing · Form 8-K | +0.49% | -0.45% |
Keep exploring
More FDMT: earnings → · analyst actions → · FDMT overview →